Related references
Note: Only part of the references are listed.Incidence and mortality of stomach cancer in China, 2014
Lei Yang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Genome-scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma
Yan-Yan Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
An expression signature model to predict lung adenocarcinoma-specific survival
Xiaoshun Shi et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma
Han-Jun Cho et al.
PLOS ONE (2018)
Cell motility in cancer invasion and metastasis: insights from simple model organisms
Christina H. Stuelten et al.
NATURE REVIEWS CANCER (2018)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
EBT: a statistic test identifying moderate size of significant features with balanced power and precision for genome-wide rate comparisons
Xinjie Hui et al.
BIOINFORMATICS (2017)
Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer
Jun Gu et al.
TUMOR BIOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Whole-genome analysis of a patient with early-stage small-cell lung cancer
J-Y Han et al.
PHARMACOGENOMICS JOURNAL (2014)
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Alexander Drilon et al.
CANCER DISCOVERY (2013)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan et al.
CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma
Ying-Wooi Wan et al.
LUNG CANCER (2012)
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi et al.
NATURE MEDICINE (2012)
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
Nikhil Wagle et al.
CANCER DISCOVERY (2012)
The malignant social network Cell-cell adhesion and communication in cancer stem cells
James S. Hale et al.
CELL ADHESION & MIGRATION (2012)
Whole Cancer Genome Sequencing by Next-Generation Methods
Jeffrey S. Ross et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Akihiko Yoshizawa et al.
MODERN PATHOLOGY (2011)
A decade's perspective on DNA sequencing technology
Elaine R. Mardis
NATURE (2011)
A small-cell lung cancer genome with complex signatures of tobacco exposure
Erin D. Pleasance et al.
NATURE (2010)
Advances in understanding cancer genomes through second-generation sequencing
Matthew Meyerson et al.
NATURE REVIEWS GENETICS (2010)
Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction
Ying-Wooi Wan et al.
PLOS ONE (2010)
New molecularly targeted therapies for lung cancer
Sophie Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinorna and bronchioloalveolar carcinoma
WD Travis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
